Products - Skin infections | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Dupilumab for treating bullous pemphigoid [ID6479]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Upadacitinib for treating moderate to severe hidradenitis suppurativa in people 12 years and over [ID6666]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Povorcitinib for treating prurigo nodularis [TSID12385]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC